Netupitant/palonosetron without dexamethasone for preventing nausea and vomiting in patients with multiple myeloma receiving high-dose melphalan for autologous stem cell transplantation: a single-center experience

MLA

Viviana Loddo, et al. “Netupitant/Palonosetron without Dexamethasone for Preventing Nausea and Vomiting in Patients with Multiple Myeloma Receiving High-Dose Melphalan for Autologous Stem Cell Transplantation: A Single-Center Experience.” Supportive Care in Cancer, vol. 30, Aug. 2021, pp. 585–91. EBSCOhost, https://doi.org/10.1007/s00520-021-06472-7.

APA

Viviana Loddo, Giuseppe Console, Antonio Maria Rossetti, Massimo Martino, Barbara Loteta, Tiziana Gangemi, Filippo Antonio Canale, Gaetana Porto, Annalisa Paviglianiti, Nicola Meliambro, Anna Ferreri, Marta Pugliese, Letteria Russo, Pasquale Fabio Provenzano, Tiziana Moscato, Domenico Porcino, Antonella Di Costanzo, Virginia Naso, Valentina Romeo, … Salvatore Gallo. (2021). Netupitant/palonosetron without dexamethasone for preventing nausea and vomiting in patients with multiple myeloma receiving high-dose melphalan for autologous stem cell transplantation: a single-center experience. Supportive Care in Cancer, 30, 585–591. https://doi.org/10.1007/s00520-021-06472-7

Chicago

Viviana Loddo, Giuseppe Console, Antonio Maria Rossetti, Massimo Martino, Barbara Loteta, Tiziana Gangemi, Filippo Antonio Canale, et al. 2021. “Netupitant/Palonosetron without Dexamethasone for Preventing Nausea and Vomiting in Patients with Multiple Myeloma Receiving High-Dose Melphalan for Autologous Stem Cell Transplantation: A Single-Center Experience.” Supportive Care in Cancer 30 (August): 585–91. doi:10.1007/s00520-021-06472-7.